Description
Description:
Restore stability of bones, Improves quality of Life “
“The 1st and only bisphosphonate approved for the prevention of skeletal metastases associated with multiple myeloma and various solid tumours”
• Inhibit bone resorption and delays onset of skeletal complications.
• Safe and highly effective for long term therapy.
• More convienient to administer than other i.v bisphosphonates.
Composition:
Strength / Packing
Each combi pack contains
One vial of :
Zoledronic Acid Monohydrate 4.264mg (Equivalent to Zoledronic Acid anhydrous 4mg)
Mannitol USP (in lyophilized form) 220 mg
And One ampule containing :
Sterile water for injection I.P 5ml
Storage Conditions: Store it at room temperature.
Key Feature:
WHO-GMP Certified
Packaging can be customize
Balanced composition
Stability
Highly effective